Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (541-550 of 556) with videos related to

Pageof 56
Sort By:
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Journal of Gastroenterology|December 5, 2022
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumYoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, et al.
Journal of Gastroenterology|March 18, 2025
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosisTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Journal of Gastroenterology and Hepatology|October 5, 2022
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in AsiaYuya Seko, Miwa Kawanaka, Hideki Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2023
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver diseaseHideki Fujii, Makoto Fujii, Michihiro Iwaki, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysisJie Li, Biyao Zou, Yee Hui Yeo, et al.
Journal of Gastroenterology|October 13, 2015
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter surveyKatsutoshi Tokushige, Hideyuki Hyogo, Tomoaki Nakajima, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 22, 2020
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitisMinami Yagi, Kosuke Matsumoto, Atsumasa Komori, et al.
Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.
Pageof 56

Showing results (541-550 of 556) with videos related to

Sort By:
Pageof 56
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Journal of Gastroenterology|December 5, 2022
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumYoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, et al.
Journal of Gastroenterology|March 18, 2025
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosisTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Journal of Gastroenterology and Hepatology|October 5, 2022
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in AsiaYuya Seko, Miwa Kawanaka, Hideki Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2023
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver diseaseHideki Fujii, Makoto Fujii, Michihiro Iwaki, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysisJie Li, Biyao Zou, Yee Hui Yeo, et al.
Journal of Gastroenterology|October 13, 2015
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter surveyKatsutoshi Tokushige, Hideyuki Hyogo, Tomoaki Nakajima, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 22, 2020
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitisMinami Yagi, Kosuke Matsumoto, Atsumasa Komori, et al.
Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.
Pageof 56